Brain Hemorrhages (Feb 2024)

Special considerations and pitfalls for intracerebral bleeding followed COVID-19 case treated by ECMO

  • Wael Osman Amer,
  • Hussein Awad El Gharieb,
  • Zakaria Ahmed,
  • Hossam Ibrahim,
  • Ahmed Alanazi,
  • Mostafa Meshref

Journal volume & issue
Vol. 5, no. 1
pp. 50 – 51

Abstract

Read online

COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated with ECMO was bleeding. COVID patients are at risk for intracerebral bleeding due to several factors, including the drug's action on ACE2 receptors, leading to hypertension, as well as hypercoagulability, dysregulated immune response, DIC, and the use of anticoagulants.

Keywords